Juan Robles, MD
Physical Medicine & Rehabilitation · Charleston, SCNPI 1508046871
Payments from drug & device makers
What this record shows
15 manufacturers reported payments, led by Abbott at 48.7% of the total. Reporting peaked in 2022 at $748 and has fallen 85.1% since, to $111 in 2025.
Across 52 payments — averaging $29.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$748
- Redhill Biopharma Inc.$240
- Daiichi Sankyo Inc.$193
- SPR Therapeutics, Inc$93
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$42
- Endo Pharmaceuticals Inc.$38
- plus $180 from 9 others
What the payments were for
- Travel & lodging$63141%
- Food & beverage$90459%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 12 | $748 |
| Redhill Biopharma Inc. | 14 | $240 |
| Daiichi Sankyo Inc. | 10 | $193 |
| SPR Therapeutics, Inc | 1 | $93 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $42 |
| Endo Pharmaceuticals Inc. | 2 | $38 |
| Amgen | 2 | $38 |
| Johnson & Johnson | 1 | $24 |
| AstraZeneca | 1 | $19 |
| Stryker | 1 | $18 |
| Biogen | 1 | $18 |
| Shionogi Inc | 1 | $18 |
| Axogen | 1 | $17 |
| Heron Therapeutics, Inc. | 1 | $16 |
| Pfizer | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$316
How this compares
$1,535 in reported general payments places this provider in the 75th percentile of 122 physical medicine & rehabilitation providers in South Carolina.
See all physical medicine & rehabilitation providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 34 | $3,440 |
| Pregabalin | 16 | $777 |
| Gabapentin | 60 | $430 |
| Naproxen | 29 | $378 |
| Ibuprofen | 44 | $185 |
| Meloxicam | 69 | $179 |
| Celecoxib | 13 | $158 |
| Cyclobenzaprine Hcl | 15 | $79 |
| Tramadol Hcl | 37 | $76 |
| Prednisone | 28 | $42 |
| Tizanidine Hcl | 11 | $31 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Charleston
- Emily DarrCharleston$5K
- David MorrowCharleston$4K
- Keith PolstonCharleston$1K
- James KefferCharleston$1K
- James EubanksCharleston$756
- Matthew SherrierCharleston$751
- Kristen RobakCharleston$550
- Caroline SmithCharleston$529
- Sybil ReddickCharleston$448
- William LorenzFlorence$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.